These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30325300)

  • 21. Analytical performance of the Hologic Aptima HBV Quant Assay and the COBAS Ampliprep/COBAS TaqMan HBV test v2.0 for the quantification of HBV DNA in plasma samples.
    Schønning K; Johansen K; Nielsen LG; Weis N; Westh H
    J Clin Virol; 2018 Jul; 104():83-88. PubMed ID: 29783147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the Roche cobas s 201 system and cobas TaqScreen multiplex test for blood screening: a European multicenter study.
    Jarvis L; Becker J; Tender A; Cleland A; Queiros L; Aquiar A; Azevedo J; Aprili G; Bressan F; Torres P; Nieto S; Ursitti A; Montoro J; Vila E; Ramada C; Saldanha J
    Transfusion; 2008 Sep; 48(9):1853-61. PubMed ID: 18513254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Cobas Ampliprep/Cobas TaqMan HBV Test versus the Cobas Amplicor HBV monitor for HBV-DNA detection and quantification during antiviral therapy.
    Allice T; Cerutti F; Pittaluga F; Varetto S; Gabella S; Marzano A; Franchello A; Ghisetti V
    New Microbiol; 2008 Jan; 31(1):27-35. PubMed ID: 18437839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter Comparison Study of both Analytical and Clinical Performance across Four Roche Hepatitis C Virus RNA Assays Utilizing Different Platforms.
    Vermehren J; Stelzl E; Maasoumy B; Michel-Treil V; Berkowski C; Marins EG; Paxinos EE; Marino E; Wedemeyer H; Sarrazin C; Kessler HH
    J Clin Microbiol; 2017 Apr; 55(4):1131-1139. PubMed ID: 28122870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological qualification of blood units: considerations about the effects of sample's handling and storage on stability of nucleic acids.
    Gessoni G; Barin P; Valverde S; Giacomini A; Di Natale C; Orlandini E; Arreghini N; De Fusco G; Frigato A; Fezzi M; Antico F; Marchiori G
    Transfus Apher Sci; 2004 Jun; 30(3):197-203. PubMed ID: 15172624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Cobas AmpliPrep/Cobas TaqMan HCV test, version 2.0, real-time PCR assay accurately quantifies hepatitis C virus genotype 4 RNA.
    Chevaliez S; Bouvier-Alias M; Rodriguez C; Soulier A; Poveda JD; Pawlotsky JM
    J Clin Microbiol; 2013 Apr; 51(4):1078-82. PubMed ID: 23325825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots.
    Maritz J; Preiser W; van Zyl GU
    J Clin Virol; 2012 Feb; 53(2):106-9. PubMed ID: 22196872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of clinical sensitivity and specificity of hepatitis B virus (HBV), hepatitis C virus, and human immunodeficiency Virus-1 by cobas MPX: Detection of occult HBV infection in an HBV-endemic area.
    Ha J; Park Y; Kim HS
    J Clin Virol; 2017 Nov; 96():60-63. PubMed ID: 28982042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analytical and clinical performance evaluation of the cobas TaqScreen MPX Test for use on the cobas s 201 system.
    Ohhashi Y; Pai A; Halait H; Ziermann R
    J Virol Methods; 2010 May; 165(2):246-53. PubMed ID: 20152864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5.
    Sarrazin C; Gärtner BC; Sizmann D; Babiel R; Mihm U; Hofmann WP; von Wagner M; Zeuzem S
    J Clin Microbiol; 2006 Mar; 44(3):729-37. PubMed ID: 16517847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of version 2.0 of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification.
    Chevaliez S; Bouvier-Alias M; Laperche S; Hézode C; Pawlotsky JM
    J Clin Microbiol; 2010 Oct; 48(10):3641-7. PubMed ID: 20720031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.
    Pas S; Rossen JW; Schoener D; Thamke D; Pettersson A; Babiel R; Schutten M
    J Clin Microbiol; 2010 Apr; 48(4):1195-200. PubMed ID: 20164281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assay.
    Pittaluga F; Allice T; Abate ML; Ciancio A; Cerutti F; Varetto S; Colucci G; Smedile A; Ghisetti V
    J Med Virol; 2008 Feb; 80(2):254-60. PubMed ID: 18098148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of on-treatment HCV RNA during direct antiviral therapy using two different COBAS TaqMan HCV assays.
    Vermehren J; Bourlière M; Pol S; Marcellin P; Hyland RH; Jiang D; Brainard DM; Zeuzem S; Welzel TM
    J Clin Virol; 2017 Apr; 89():51-56. PubMed ID: 28259054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance.
    Pyne MT; Brown KL; Hillyard DR
    J Clin Microbiol; 2010 Aug; 48(8):2852-8. PubMed ID: 20573864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.
    Yang Z; Xu L; Liu L; Feng Q; Zhang L; Ma W; Saldanha J; Wang M; Zhao L
    Transfusion; 2013 Oct; 53(10 Pt 2):2538-44. PubMed ID: 23480568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy.
    Mücke MM; Maasoumy B; Dietz J; Mücke VT; Simon CO; Canchola JA; Cornberg M; Marins EG; Manns MP; Zeuzem S; Wedemeyer H; Sarrazin C; Vermehren J
    PLoS One; 2019; 14(11):e0224751. PubMed ID: 31738773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter evaluation of the cobas® HIV-1 quantitative nucleic acid test for use on the cobas® 4800 system for the quantification of HIV-1 plasma viral load.
    Adams P; Vancutsem E; Nicolaizeau C; Servais JY; Piérard D; François JH; Schneider T; Paxinos EE; Marins EG; Canchola JA; Seguin-Devaux C
    J Clin Virol; 2019 May; 114():43-49. PubMed ID: 30991164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors.
    Wiedmann M; Kluwick S; Walter M; Fauchald G; Howe J; Bronold M; Zauke M
    J Clin Virol; 2007 Aug; 39(4):282-7. PubMed ID: 17611148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.